These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 20186004)

  • 21. Developing antibodies for targeting immunoglobulin and membrane-bound immunoglobulin E.
    Chang TW
    Allergy Asthma Proc; 2006; 27(2 Suppl 1):S7-14. PubMed ID: 16722326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evolution in immunological methods used in research and in the clinical diagnosis and management of human allergic diseases.
    Hamilton RG
    J Immunol Methods; 2012 Sep; 383(1-2):1-3. PubMed ID: 22750249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Specific and nonspecific (anti-IgE) immunotherapy of allergic diseases].
    Pichler WJ
    Ther Umsch; 2001 May; 58(5):329-36. PubMed ID: 11407237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone marrow of NZB/W mice is the major site for plasma cells resistant to dexamethasone and cyclophosphamide: implications for the treatment of autoimmunity.
    Mumtaz IM; Hoyer BF; Panne D; Moser K; Winter O; Cheng QY; Yoshida T; Burmester GR; Radbruch A; Manz RA; Hiepe F
    J Autoimmun; 2012 Sep; 39(3):180-8. PubMed ID: 22727274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients.
    Rossi RE; Monasterolo G
    Int Arch Allergy Immunol; 2004 Sep; 135(1):44-53. PubMed ID: 15286445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IgE-facilitated antigen presentation: role in allergy and the influence of allergen immunotherapy.
    Wilcock LK; Francis JN; Durham SR
    Immunol Allergy Clin North Am; 2006 May; 26(2):333-47, viii-ix. PubMed ID: 16701148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-IgE (omalizumab) inhibits late-phase reactions and inflammatory cells after repeat skin allergen challenge.
    Ong YE; Menzies-Gow A; Barkans J; Benyahia F; Ou TT; Ying S; Kay AB
    J Allergy Clin Immunol; 2005 Sep; 116(3):558-64. PubMed ID: 16159624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treating IgE-mediated diseases via targeting IgE-expressing B cells using an anti-CεmX antibody.
    Liour SS; Tom A; Chan YH; Chang TW
    Pediatr Allergy Immunol; 2016 Aug; 27(5):446-51. PubMed ID: 27090058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-IgE for the treatment of allergic rhinitis--and eventually nasal polyps?
    Verbruggen K; Van Cauwenberge P; Bachert C
    Int Arch Allergy Immunol; 2009; 148(2):87-98. PubMed ID: 18799888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renaissance of the blocking antibody concept in type I allergy.
    Flicker S; Valenta R
    Int Arch Allergy Immunol; 2003 Sep; 132(1):13-24. PubMed ID: 14555854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IgE+ B cells are scarce, but allergen-specific B cells with a memory phenotype circulate in patients with allergic rhinitis.
    Wong KJ; Timbrell V; Xi Y; Upham JW; Collins AM; Davies JM
    Allergy; 2015 Apr; 70(4):420-8. PubMed ID: 25556717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surface plasmon resonance analysis of free IgE in allergic patients receiving omalizumab (Xolair).
    Hamilton RG; Saini SS; MacGlashan D
    J Immunol Methods; 2012 Sep; 383(1-2):54-9. PubMed ID: 22658968
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-BR3 antibodies: a new class of B-cell immunotherapy combining cellular depletion and survival blockade.
    Lin WY; Gong Q; Seshasayee D; Lin Z; Ou Q; Ye S; Suto E; Shu J; Lee WP; Lee CW; Fuh G; Leabman M; Iyer S; Howell K; Gelzleichter T; Beyer J; Danilenko D; Yeh S; DeForge LE; Ebens A; Thompson JS; Ambrose C; Balazs M; Starovasnik MA; Martin F
    Blood; 2007 Dec; 110(12):3959-67. PubMed ID: 17687108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-immunoglobulin E therapy for asthma.
    Owen CE
    Pulm Pharmacol Ther; 2002; 15(5):417-24. PubMed ID: 12406663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-IgE monoclonal antibody: a new approach to the treatment of allergic respiratory diseases.
    D'Amato G; Oldani V; Donner CF
    Monaldi Arch Chest Dis; 2003; 59(1):25-9. PubMed ID: 14533279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proteasome inhibition with bortezomib induces a therapeutically relevant depletion of plasma cells in SLE but does not target their precursors.
    Alexander T; Cheng Q; Klotsche J; Khodadadi L; Waka A; Biesen R; Hoyer BF; Burmester GR; Radbruch A; Hiepe F
    Eur J Immunol; 2018 Sep; 48(9):1573-1579. PubMed ID: 29979809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tolerability of retreatment with omalizumab, a recombinant humanized monoclonal anti-IgE antibody, during a second ragweed pollen season in patients with seasonal allergic rhinitis.
    Nayak A; Casale T; Miller SD; Condemi J; McAlary M; Fowler-Taylor A; Della Cioppa G; Gupta N
    Allergy Asthma Proc; 2003; 24(5):323-9. PubMed ID: 14619332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. From allergy to anti-IgE: targeting the cause.
    Oldani V
    Monaldi Arch Chest Dis; 2002 Apr; 57(2):115-6. PubMed ID: 12357839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. From IgE to clinical trials of allergic rhinitis.
    Ciprandi G; Marseglia GL; Castagnoli R; Valsecchi C; Tagliacarne C; Caimmi S; Licari A
    Expert Rev Clin Immunol; 2015; 11(12):1321-33. PubMed ID: 26358006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduction of total IgE by targeted coengagement of IgE B-cell receptor and FcγRIIb with Fc-engineered antibody.
    Chu SY; Horton HM; Pong E; Leung IW; Chen H; Nguyen DH; Bautista C; Muchhal US; Bernett MJ; Moore GL; Szymkowski DE; Desjarlais JR
    J Allergy Clin Immunol; 2012 Apr; 129(4):1102-15. PubMed ID: 22257644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.